Latest Regulatory Framework News

Skylark Minerals Limited has applied for ASX quotation of 17,577,446 fully paid ordinary shares linked to a previously announced placement, with further shares pending shareholder approval.

ECS Botanics is strategically preparing for entry into the US medicinal cannabis market, leveraging its EU-GMP certification and proprietary genetics amid evolving regulatory landscapes.

Lake Resources has disclosed an inadvertent breach of ASX Listing Rule 7.1 related to the timing of share issuance under an agreement with Acuity Capital. The company is taking steps to strengthen governance and prevent future errors.

Zeus Resources has secured Forestry Department approval to begin trenching at its Casablanca Antimony Project in Morocco, clearing a key regulatory hurdle for exploration. The program aims to refine geological understanding and target high-grade antimony mineralization.

Embark Early Education has successfully completed a $12 million placement to support its conditional takeover bid for Mayfield Childcare. The capital raise attracted strong backing from existing and new sophisticated investors.

Tasman Resources has completed the second tranche of its $2 million share placement, issuing 92 million shares and raising $1.15 million before costs. The company confirms full compliance with regulatory requirements in its updated cleansing notice.

Fidante Partners Limited has issued a replacement Product Disclosure Statement for the Ardea Real Outcome Bond Complex ETF, reducing transaction costs while maintaining its core investment strategy and fee structure.

Robex Resources and Predictive Discovery have amended their arrangement agreement, reducing the exchange ratio and delaying the shareholder meeting to late December. Major shareholders have recommitted to support the deal, which awaits court approval.

Prospech Limited has significantly increased its Jokikangas project tenure in northern Finland, targeting critical minerals like yttrium and niobium amid soaring European prices. The expansion positions the company strongly within a Tier-1 mining jurisdiction as it plans initial exploration activities.

South Harz Potash has submitted three new exploration licence applications in Sweden’s Värmland Province, significantly expanding its copper-gold project area near the existing Glava 100 site.

Cauldron Energy has announced a significant new uranium discovery at its Manyingee North prospect, with high-grade mineralisation intersected in all recent drillholes, suggesting a substantial expansion of its Yanrey Uranium Project resource base.

InhaleRx has boosted its funding facility by $12.6 million to accelerate clinical trials of SRX-25, a novel oral treatment for Treatment-Resistant Depression. This brings total available capital to $52.3 million, positioning the company for pivotal Phase III studies.